Terre Property Partners and Noumed turn the sod on $100M Pharmaceutical Manufacturing facility

Construction has officially commenced on an $100M purpose-built facility for  Noumed Pharmaceuticals in South Australia’s northern suburbs, which will be the most modern of its kind in Australia. 

Noumed’s state-of-the-art pharmaceutical manufacturing plant will enhance Australia’s sovereign supply into the pharmacy and health networks, by manufacturing certain OTC pharmaceutical products in South Australia rather than being manufactured overseas. 

During stage 1, Noumed will manufacture liquid-based products such as cough mixtures, children’s suspensions, and nasal perforations, as well as creams and packing solid dose tablets, while stage 2 will enable the company to manufacture solid dose tablets. 

The manufacturing plant, which is being built on a 43,000 sqm site and has a floor area of 26,000sqm, will join several other prominent national and international companies in Terre Property Partners’ Nexus North Industrial Estate, including Asahi, Telstra, Haighs Chocolates, and FJT Logistics.

The project is expected to create 250 jobs in South Australia during construction and Noumed will employ more than 180 people when local production begins in 2026. 

Terre Property Partners CEO, Mark Brammy, is excited to be the development and ongoing partner for the modern pharmaceutical manufacturing facility.

“We are thrilled to continue our relationship with Noumed Pharmaceuticals within the Nexus North Industrial Estate.

“The location is an ideal place for high-tech industries and we’re looking forward to Noumed leading the way in Australian pharmaceutical manufacturing, right here in South Australia,” Mr Brammy said.

Noumed’s Managing Director, Mark Thulborne, added how the company is excited to reach its goal of bringing manufacturing back into Australia and expanding investment in South Australia.

“By coming back into Australia, current and future clients can have the comfort that many of their products are being made in South Australia. This means a shorter lead time to their shelves and a supplier that can react quickly to their individual needs.

“I think this demonstrates our long-term commitment to the customers we serve, and it will give them an unmatched competitive advantage,” Mr Thulborne said.

The new manufacturing plant will receive up to $20million in Australian Government funding and is a key part of the state’s 10-year health and medical industries strategy. The project is expected to create 250 jobs during construction and Noumed will employ more than 180 people when local production begins in 2026.

Terre congratulates Noumed on reaching this exciting milestone, and acknowledges TMX and FDC for their contribution to the design and development of this project.